The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Francisco Gracia‐Navarro(University of Córdoba), Michael D. Culler(Ipsen (United States)), David Rincon Fernandez Pacheco(Cedars-Sinai Medical Center), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Oriol Casanovas(Institut Català d'Oncologia), Gema Moreno‐Bueno(Centro de Investigación Biomédica en Red de Cáncer), Alejandro Rojo‐Sebastián(MD Anderson Cancer Center Madrid), Mario Durán‐Prado(Hospital General Universitario de Ciudad Real), Marta Hergueta‐Redondo(Spanish National Cancer Research Centre), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 20
Related Papers
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390